Literature DB >> 7678069

Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential.

L Lu1, M Xiao, R N Shen, S Grigsby, H E Broxmeyer.   

Abstract

To characterize the growth of cord blood progenitor cells, single nonadherent, low-density, T-lymphocyte-depleted CD34 cells were sorted by flow cytometer with an autoclone device into single wells containing culture medium and cytokines. These cells were evaluated for proliferation and for replating ability of their progeny. This latter effect is used as a measure of self-renewal capacity. Colony formation was assessed in 1 degree wells containing various cytokines, alone and in combination, and single colonies deriving after 21 days in semisolid medium were replated into 2 degree wells in the presence of the combination of purified preparations of recombinant human steel factor (SF, a c-kit ligand), granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), interleukin-3 (IL-3), and erythropoietin (Epo). Replating of single colonies was performed also for 3 degrees, 4 degrees, and 5 degrees cultures. In the presence of serum, colony formation was observed in > 66% of the wells stimulated with the combination of Epo, SF, GM-CSF, G-CSF, and IL-3, and more than 39% of the colonies formed in these 1 degree wells were very large in size (> 2.5 mm in diameter, dense in the center, and containing > 10(4) cells/colony). The replating efficiency of these large colonies was up to 93% with generation of subsequent colonies of very large size. Replating could be shown for up to five generations. The cells in these colonies were large, nonspecific esterase positive, and contained large amounts of cytoplasm with one or more nuclei containing several nucleoli per nucleus. Smaller colonies (1 to 2.5 mm in diameter and dense in the center) containing similar cells and making up an additional 14% of the colonies formed in 1 degree wells also showed extensive replating capacity, including generation of larger colonies. These colony-forming cells are likely similar to the murine macrophage high-proliferative potential colony-forming cells. The cells giving rise to these colonies are present in about eightfold higher frequency in cord blood than in adult bone marrow. These cells may at least in part be associated with the successful hematopoietic repopulating capacity of umbilical cord blood cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678069

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

Review 1.  Hematopoietic stem cell gene therapy.

Authors:  David W Emery; Tamon Nishino; Ken Murata; Michalis Fragkos; George Stamatoyannopoulos
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

Review 2.  Cord blood stem cells for hematopoietic transplantation.

Authors:  Anfisa Stanevsky; Avichai Shimoni; Ronit Yerushalmi; Arnon Nagler
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

3.  Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4.

Authors:  Yong-Hao Hou; Edward F Srour; Heather Ramsey; Richard Dahl; Hal E Broxmeyer; Robert Hromas
Journal:  Blood       Date:  2005-01-13       Impact factor: 22.113

4.  Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.

Authors:  Stephanie B Tsai; Hongtao Liu; Tsiporah Shore; Yun Fan; Michael Bishop; Melissa M Cushing; Usama Gergis; Lucy Godley; Justin Kline; Richard A Larson; Guadalupe Martinez; Sebastian Mayer; Olatoyosi Odenike; Wendy Stock; Amittha Wickrema; Koen van Besien; Andrew S Artz
Journal:  Biol Blood Marrow Transplant       Date:  2016-02-19       Impact factor: 5.742

5.  Long-term culture system for selective growth of human B-cell progenitors.

Authors:  D J Rawlings; S G Quan; R M Kato; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system.

Authors:  Susana Cantero Peral; Harold M Burkhart; Saji Oommen; Satsuki Yamada; Scott L Nyberg; Xing Li; Patrick W O'Leary; Andre Terzic; Bryan C Cannon; Timothy J Nelson
Journal:  Stem Cells Transl Med       Date:  2015-01-05       Impact factor: 6.940

Review 7.  Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function.

Authors:  Hal E Broxmeyer
Journal:  Ann N Y Acad Sci       Date:  2012-08       Impact factor: 5.691

8.  Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults.

Authors:  A A Cardoso; M L Li; P Batard; A Hatzfeld; E L Brown; J P Levesque; H Sookdeo; B Panterne; P Sansilvestri; S C Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Separation, enrichment, and characterization of human hematopoietic progenitor cells from umbilical cord blood.

Authors:  J H Falkenburg; S A van Luxemburg-Heijs; J M Zijlmans; W E Fibbe; J C Kluin-Nelemans; H H Kanhai; R Willemze
Journal:  Ann Hematol       Date:  1993-11       Impact factor: 3.673

Review 10.  Umbilical cord blood transplantation: the first 25 years and beyond.

Authors:  Karen K Ballen; Eliane Gluckman; Hal E Broxmeyer
Journal:  Blood       Date:  2013-05-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.